Tyra Biosciences, Inc. (TYRA)
32.44
-1.36
(-4.02%)
USD |
NASDAQ |
May 07, 13:40
Tyra Biosciences SG&A Expense (TTM) : 29.83M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Spyre Therapeutics, Inc. | 35.96M |
| Entrada Therapeutics, Inc. | 41.05M |
| BioMarin Pharmaceutical, Inc. | 946.91M |
| Ionis Pharmaceuticals, Inc. | 467.79M |
| Agios Pharmaceuticals, Inc. | 187.06M |